SEARCH

SEARCH BY CITATION

References

  • 1
    American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35 Suppl 1:S64S71.
  • 2
    Galtier F: Definition, epidemiology, risk factors. Diabetes Metab 2010; 36:628651.
  • 3
    Ferrara A: Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007; 30(Suppl 2):S141S146.
  • 4
    Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33:676682.
  • 5
    Jenum AK, Morkrid K, Sletner L, Vangen S, Torper JL, Nakstad B, Voldner N, Rognerud-Jensen OH, Berntsen S, Mosdol A, Skrivarhaug T, Vardal MH, Holme I, Yajnik CS, Birkeland KI: Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol 2012; 166:317324.
  • 6
    Reece EA: The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2010; 23:199203.
  • 7
    Matarese G, Procaccini C, de Rosa V: At the crossroad of T cells, adipose tissue, and diabetes. Immunol Rev 2012; 249:116134.
  • 8
    Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11:98107.
  • 9
    Richardson AC, Carpenter MW: Inflammatory mediators in gestational diabetes mellitus. Obstet Gynecol Clin North Am 2007; 34:213224.
  • 10
    Commins SP, Borish L, Steinke JW: Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 2010; 125:S53S72.
  • 11
    Daher S, de ArrudaGeraldesDenardi K, Blotta MH, Mamoni RL, Reck AP, Camano L, Mattar R: Cytokines in recurrent pregnancy loss. J Reprod Immunol 2004; 62:151157.
  • 12
    Palmirotta R, La Farina F, Ferroni P, Ludovici G, Nigro C, Savonarola A, Raparelli V, Riondino S, Rampini MR, Guadagni F, Basili S: TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in Italian women. Reprod Sci 2010; 17:659666.
  • 13
    Jenkins C, Roberts J, Wilson R, MacLean MA, Shilito J, Walker JJ: Evidence of a T(H) 1 type response associated with recurrent miscarriage. Fertil Steril 2000; 73:12061208.
  • 14
    Saito S, Nakashima A, Shima T, Ito M: Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63:601610.
  • 15
    Fuentes L, Roszer T, Ricote M: Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages. Mediators Inflamm 2010;2010:219583.
  • 16
    Salmi AA, Zaki NM, Zakaria R, Nor Aliza AG, Rasool AH: Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus. Vasa 2012; 41:96104.
  • 17
    Lopez-Tinoco C, Roca M, Fernandez-Deudero A, Garcia-Valero A, Bugatto F, Aguilar-Diosdado M, Bartha JL: Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 2012; 58:1419.
  • 18
    Altinova AE, Toruner F, Bozkurt N, Bukan N, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M: Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus. Gynecol Endocrinol 2007; 23:161165.
  • 19
    McLachlan KA, O'Neal D, Jenkins A, Alford FP: Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy Diabetes Metab Res Rev 2006; 22:131138.
  • 20
    Kinalski M, Telejko B, Kuzmicki M, Kretowski A, Kinalska I: Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 2005; 37:450454.
  • 21
    Winkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajos P, Salamon F, Turi Z, Kovacs M, Vargha P, Karadi I: Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract 2002; 56:9399.
  • 22
    Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM: TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51:22072213.
  • 23
    Gueuvoghlanian-Silva BY, Torloni MR, Mattar R, de Oliveira LS, Scomparini FB, Nakamura MU, Daher S: Profile of inflammatory mediators in gestational diabetes mellitus: phenotype and genotype. Am J Reprod Immunol 2012; 67:241250.
  • 24
    Saucedo R, Zarate A, Basurto L, Hernandez M, Puello E, Galvan R, Campos S: Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 2011; 42:318323.
  • 25
    Montazeri S, Nalliah S, Radhakrishnan AK: Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? Hereditas 2010; 147:94102.
  • 26
    Gao XL, Yang HX, Zhao Y: Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J (Engl) 2008; 121:701705.
  • 27
    Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, Hiscock R, Permezel M, Khalil Z, Rice GE: Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008; 45:157165.
  • 28
    Palik E, Baranyi E, Melczer Z, Audikovszky M, Szocs A, Winkler G, Cseh K: Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 2007; 76:351357.
  • 29
    Kuzmicki M, Telejko B, Zonenberg A, Szamatowicz J, Kretowski A, Nikolajuk A, Laudanski P, Gorska M: Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes. Horm Metab Res 2008; 40:556560.
  • 30
    Peltier MR, Drobek CO, Bhat G, Saade G, Fortunato SJ, Menon R: Amniotic fluid and maternal race influence responsiveness of fetal membranes to bacteria. J Reprod Immunol 2012; 96:6878.
  • 31
    Velez DR, Fortunato SJ, Morgan N, Edwards TL, Lombardi SJ, Williams SM, Menon R: Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod 2008; 23:19021909.
  • 32
    Pacheco KA: Epigenetics mediate environment: gene effects on occupational sensitization. Curr Opin Allergy Clin Immunol 2012; 12:111118.
  • 33
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:20082012.
  • 34
    Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3:25.
  • 35
    Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:15391558.
  • 36
    Hasselblad V, McCrory DC: Meta-analytic tools for medical decision making: a practical guide. Med Decis Making 1995; 15:8196.
  • 37
    Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003; 327:557560.
  • 38
    Normand SL: Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999; 18:321359.
  • 39
    Abdel Gader AG, Khashoggi TY, Habib F, Awadallah SB: Haemostatic and cytokine changes in gestational diabetes mellitus. Gynecol Endocrinol 2011; 27:356360.
  • 40
    Cseh K, Baranyi E, Melczer Z, Csakany GM, Speer G, Kovacs M, Gero G, Karadi I, Winkler G: The pathophysiological influence of leptin and the tumor necrosis factor system on maternal insulin resistance: negative correlation with anthropometric parameters of neonates in gestational diabetes. Gynecol Endocrinol 2002; 16:453460.
  • 41
    Kalabay L, Cseh K, Pajor A, Baranyi E, Csakany GM, Melczer Z, Speer G, Kovacs M, Siller G, Karadi I, Winkler G: Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol 2002; 147:243248.
  • 42
    Kuzmicki M, Telejko B, Szamatowicz J, Zonenberg A, Nikolajuk A, Kretowski A, Gorska M: High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009; 25:258263.
  • 43
    Lapolla A, Dalfra MG, Sanzari M, Fedele D, Betterle C, Masin M, Zanchetta R, Faggian D, Masotti M, Nucera V, Plebani M: Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. Cytokine 2005; 31:280287.
  • 44
    Lygnos MC, Pappa KI, Papadaki HA, Relakis C, Koumantakis E, Anagnou NP, Eliopoulos GD: Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo 2006; 20:157163.
  • 45
    Morisset AS, Dube MC, Cote JA, Robitaille J, Weisnagel SJ, Tchernof A: Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand 2011; 90:524530.
  • 46
    Vitoratos N, Valsamakis G, Mastorakos G, Boutsiadis A, Salakos N, Kouskouni E, Creatsas G: Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes. Hormones (Athens) 2008; 7:230236.
  • 47
    Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA: Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91:41374143.
  • 48
    Bo S, Signorile A, Menato G, Gambino R, Bardelli C, Gallo ML, Cassader M, Massobrio M, Pagano GF: C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest 2005; 28:779786.
  • 49
    Friedman JE, Kirwan JP, Jing M, Presley L, Catalano PM: Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes 2008; 57:606613.
  • 50
    Habib FA: Evaluation of periodontal status among Saudi females with gestational diabetes and its relation to glucose and lipid homeostasis in Ohud Hospital, Al-Madina Al-Munwarrah. Int J Health Sci (Qassim) 2009; 3:143154.
  • 51
    Lappas M, Permezel M, Rice GE: Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89:56275633.
  • 52
    Montazeri S, Nalliah S, Radhakrishnan AK: Association between polymorphisms in human tumor necrosis factor-alpha (–308) and -beta (252) genes and development of gestational diabetes mellitus. Diabetes Res Clin Pract 2010; 88:139145.
  • 53
    Moreli JB, Morceli G, de Luca AK, Magalhaes CG, Costa RA, Damasceno DC, Rudge MV, Calderon IM: Influence of maternal hyperglycemia on IL-10 and TNF-alpha production: the relationship with perinatal outcomes. J Clin Immunol 2012; 32:604610.
  • 54
    Poyhonen-Alho M, Ebeling P, Saarinen A, Kaaja R: Decreased variation of inflammatory markers in gestational diabetes. Diabetes Metab Res Rev 2011; 27:269276.
  • 55
    Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S: Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52:29512958.
  • 56
    Tsiotra PC, Tsigos C, Yfanti E, Anastasiou E, Vikentiou M, Psarra K, Papasteriades C, Raptis SA: Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Horm Metab Res 2007; 39:758763.
  • 57
    Swaroop JJ, Rajarajeswari D, Naidu JN: Association of TNF-alpha with insulin resistance in type 2 diabetes mellitus. Indian J Med Res 2012; 135:127130.
  • 58
    Devaraj S, Venugopal SK, Singh U, Jialal I: Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes 2005; 54:8591.
  • 59
    Smith MM, Minson CT: Obesity and adipokines: effects on sympathetic overactivity. J Physiol 2012; 590:17871801.
  • 60
    van Exel E, Gussekloo J, de Craen AJ, Frolich M, Bootsma-Van DerWiel A, Westendorp RG: Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 2002; 51:10881092.